NKGN
NKGen Biotech, Inc. Common Stock
NKGN
NKGN
Delisted
NKGN was delisted on the 4th of March, 2025.
48 hedge funds and large institutions have $123M invested in NKGen Biotech, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 3 closing their positions.
Holders
48
Holders Change
+5
Holders Change %
+11.63%
% of All Funds
0.81%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
4
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
SCC
1
Spring Creek Capital
Wichita,
Kansas
|
$0 |
2 |
2
Bank of America
Charlotte,
North Carolina
|
$0 |
3 |
SG
3
StoneX Group
New York
|
$0 |
4 |
4
HighTower Advisors
Chicago,
Illinois
|
$313K |